| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0.15 (Beat by $0.08) |
| EPS GAAP Actual | $0.15 (Beat by $0.08) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.03 |
| EPS GAAP Estimate | $0.03 |
| Revenue Estimate | $0.793484B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0.38 | 60.45 | 0.38 | 0.38 | 1 |
| Dec 2026 | 0.37 | 62.08 | 0.37 | 0.37 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.36 | 0.18 | 0B | -INF% | -844.69M |
| FQ2 2025 (Jun 2025) | 0.6428 | 0.3228 | 0.961925B | -17.82% | 121.15M |
| FQ1 2025 (Mar 2025) | -0.19 | -0.35 | 0B | -INF% | -775.9M |
| FQ4 2024 (Dec 2024) | 0.44 | 0.44 | 0.100983B | -904.8% | 100.98M |
| FQ3 2024 (Sep 2024) | 0.28 | 0.28 | 2.0471B | -13.31% | 2047.1M |
| FQ2 2024 (Jun 2024) | 0.31 | 0.31 | 1.13336B | -93.5% | 1133.36M |
| FQ1 2024 (Mar 2024) | -0.48 | -0.48 | 0.941548B | -7.92% | 941.55M |
| FQ4 2023 (Dec 2023) | 0.0004 | 0.0004 | 1.01468B | -10.85% | 1014.68M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.03
Consensus Revenue Estimates
0.793484B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.07 | -- | 0.07 | 0.07 | 1 |
| FQ3 2027 (Sep 2027) | 0.14 | -- | 0.14 | 0.14 | 1 |
| FQ2 2027 (Jun 2027) | 0.12 | -- | 0.12 | 0.12 | 1 |
| FQ1 2027 (Mar 2027) | 0.05 | -- | 0.05 | 0.05 | 1 |
| FQ4 2026 (Dec 2026) | 0.04 | -- | 0.04 | 0.04 | 1 |
| FQ3 2026 (Sep 2026) | 0.16 | -125 | 0.16 | 0.16 | 1 |
| FQ2 2026 (Jun 2026) | 0.14 | -359.14 | 0.14 | 0.14 | 1 |
| FQ1 2026 (Mar 2026) | 0.03 | 733.33 | 0.03 | 0.03 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.83B | -- | 0.83B | 0.83B | 1 |
| FQ3 2027 (Sep 2027) | 0.85B | -- | 0.85B | 0.85B | 1 |
| FQ2 2027 (Jun 2027) | 0.84B | -- | 0.84B | 0.84B | 1 |
| FQ1 2027 (Mar 2027) | 0.81B | -- | 0.81B | 0.81B | 1 |
| FQ4 2026 (Dec 2026) | 0.81B | -- | 0.81B | 0.81B | 1 |
| FQ3 2026 (Sep 2026) | 0.83B | -- | 0.83B | 0.83B | 1 |
| FQ2 2026 (Jun 2026) | 0.82B | -17.02 | 0.82B | 0.82B | 1 |
| FQ1 2026 (Mar 2026) | 0.79B | -- | 0.79B | 0.79B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.18 | 0.36 | 0.18 | 50% |
| FQ2 2025 (Jun 2025) | 0.32 | 0.6428 | 0.3228 | 50.22% |
| FQ1 2025 (Mar 2025) | 0.16 | -0.19 | -0.35 | 184.21% |
| FQ4 2024 (Dec 2024) | 0.44 | 0.44 | 100% | |
| FQ3 2024 (Sep 2024) | 0.28 | 0.28 | 100% | |
| FQ2 2024 (Jun 2024) | 0.31 | 0.31 | 100% | |
| FQ1 2024 (Mar 2024) | -0.48 | -0.48 | 100% | |
| FQ4 2023 (Dec 2023) | 0.0004 | 0.0004 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.84B | $0B | $-844.69M | -INF% |
| FQ2 2025 (Jun 2025) | $0.84B | $0.96B | $121.15M | 12.59% |
| FQ1 2025 (Mar 2025) | $0.78B | $0B | $-775.9M | -INF% |
| FQ4 2024 (Dec 2024) | $0B | $0.1B | $100.98M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.05B | $2047.1M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.13B | $1133.36M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.94B | $941.55M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.01B | $1014.68M | 100% |